世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

NSCLC向け標的薬EGFR RTK阻害剤の世界市場の現状、動向、COVID-19影響レポート2021年版


Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Status, Trends and COVID-19 Impact Report 2021

NSCLC向け標的薬EGFR RTK阻害剤の世界市場の現状、動向、COVID-19影響レポート2021年版 シングルユーザーライセンスレポート:2350ドル コーポレートユーザーライセンスレポート:4700ドル セクションの価格です... もっと見る

 

 

出版社 出版年月 電子版価格 言語
BisReport Consulting Co., Ltd.
BISレポートコンサルティング
2022年3月21日 US$2,350
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

NSCLC向け標的薬EGFR RTK阻害剤の世界市場の現状、動向、COVID-19影響レポート2021年版
シングルユーザーライセンスレポート:2350ドル
コーポレートユーザーライセンスレポート:4700ドル
セクションの価格です。以下の通り

過去数年間で、NSCLC用標的薬EGFR RTK阻害剤市場は、COVID-19の影響下で大きな変化を経験し、NSCLC用標的薬EGFR RTK阻害剤の世界市場規模は2016年に(2016市場規模XXXX)から2021年には(2021市場規模XXXX)万ドルに達し、2016年から2021年のCAGRはXXXである。現時点では、世界のCOVID-19コロナウイルスCasesは2億を超えており、世界的な流行は基本的に制御されている、したがって、世界銀行は、2021年と2022年の世界経済の成長を推定しています。世界銀行の予測では、2021年の世界経済生産は4%拡大する一方、2022年は3.8%拡大する見込みです。NSCLC向けTargeted Drug EGFR RTK Inhibitorsの市場と世界経済環境に関する調査によると、NSCLC向けTargeted Drug EGFR RTK Inhibitorsの世界市場規模は2026年に(2026年市場規模XXXX)万ドルに達し、2021年から2026年の年平均成長率は%と予測されます。

COVID-19のパンデミックにより、世界銀行の統計によると、2020年の世界のGDPは約3.5%縮小しています。2021年に入り、多くの国で経済活動が回復し始め、パンデミックの制限に部分的に適応しています。ワクチンの研究開発が画期的に進展し、多くの政府も米国を中心に景気回復を促す様々な政策を打ち出しており、経済活動に強い追い風となりそうだが、持続的成長の見通しは国やセクターによって大きく異なる。世界経済は、COVID-19による大不況から回復しつつありますが、パンデミック前のトレンドを下回る状態が長期に続くと思われます。パンデミックは、10年にわたる世界的な債務蓄積の波に伴うリスクを悪化させた。また、今後10年間に予想される潜在成長率の鈍化を急進させる可能性が高い。

世界はCOVID-19の流行回復期に入りました。この複雑な経済環境の中で、我々は、NSCLC用グローバル標的薬EGFR RTK阻害剤市場の現状、動向とCOVID-19影響レポート2021を公開し、NSCLC用グローバル標的薬EGFR RTK阻害剤市場の包括的な分析を提供します 、このレポートは、以下を含むメーカーデータをカバーしています:販売量、価格、収益、総利益、事業分布など、これらのデータは、消費者が競合他社についてよりよく知ってもらうことができます。また、本レポートは世界のすべての地域と国をカバーしており、市場規模、数量、価値、価格データなど、地域の発展状況を示しています。さらに、このレポートでは、次のようなセグメントデータもカバーしています:タイプ別、産業別、チャネル別などすべてのデータ期間は2015年から2021Eまでで、このレポートはまた2021年から2026年の予測データを提供します。

セクション1:100ドル--市場概要

セクション(2 3):1200米ドル--メーカー詳細
ベータファーマ
アストラゼネカ
ナトコファーマ
斉魯薬業
ジェネンテック(ロシュグループ)
マイラン
テバ
OSIファーマシューティカルズ
グレンマーク・ファーマシューティカルズ
ビーコン・ファーマシューティカルズ
ベーリンガーインゲルハイム
ファイザー
アリアド・ファーマシューティカルズ(武田薬品)
ジェンビオファーマ株式会社
ドラッグ インターナショナル リミテッド
エベレスト・ファーマシューティカルズ
インセプタ・ファーマシューティカルズ・リミテッド
シプラ・ファーマ
ドクター・レディーズ・ラボラトリーズ
ザイダス・カディラ
ヘテロドラッグス
インタス・ファーマシューティカルズ
アルケムラボラトリーズ
RPGライフサイエンス
フレゼニウス・カビ・インディア

セクション4:900ドル--地域別区分
北米(米国、カナダ、メキシコ)
南米(ブラジル、アルゼンチン、その他)
アジア太平洋地域(中国、日本、インド、韓国、東南アジア)
欧州(ドイツ、イギリス、フランス、スペイン、イタリア)
中東・アフリカ(中近東、アフリカ)

セクション(5 6 7): 700米ドル--。
製品タイプ別セグメント
イコチニブ
ゲフィチニブ
エルロチニブ
アファチニブ
オシメルチニブ

アプリケーション区分
NSCLCの扁平上皮癌
NSCLCの腺癌
NSCLCの大細胞癌

チャネル(直販、流通)別セグメント

セクション8:500米ドル--市場予測(2021-2026年)

セクション9:600米ドル--川下顧客

第10節: 200米ドル--原材料と製造コスト

第11章:500ドル--結論

第12章:調査方法とデータソース



ページTOPに戻る


目次

Table of Contents
Section 1 Targeted Drug EGFR RTK Inhibitors for NSCLC Market Overview
1.1 Targeted Drug EGFR RTK Inhibitors for NSCLC Market Scope
1.2 COVID-19 Impact on Targeted Drug EGFR RTK Inhibitors for NSCLC Market
1.3 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Status and Forecast Overview
1.3.1 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Status 2016-2021
1.3.2 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Forecast 2021-2026

Section 2 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Manufacturer Share
2.1 Global Manufacturer Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume
2.2 Global Manufacturer Targeted Drug EGFR RTK Inhibitors for NSCLC Business Revenue

Section 3 Manufacturer Targeted Drug EGFR RTK Inhibitors for NSCLC Business Introduction
3.1 Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Business Introduction
3.1.1 Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume, Price, Revenue and Gross margin 2016-2021
3.1.2 Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Business Distribution by Region
3.1.3 Beta Pharma Interview Record
3.1.4 Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Business Profile
3.1.5 Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Product Specification

3.2 AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Business Introduction
3.2.1 AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume, Price, Revenue and Gross margin 2016-2021
3.2.2 AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Business Distribution by Region
3.2.3 Interview Record
3.2.4 AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Business Overview
3.2.5 AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Product Specification

3.3 Manufacturer three Targeted Drug EGFR RTK Inhibitors for NSCLC Business Introduction
3.3.1 Manufacturer three Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume, Price, Revenue and Gross margin 2016-2021
3.3.2 Manufacturer three Targeted Drug EGFR RTK Inhibitors for NSCLC Business Distribution by Region
3.3.3 Interview Record
3.3.4 Manufacturer three Targeted Drug EGFR RTK Inhibitors for NSCLC Business Overview
3.3.5 Manufacturer three Targeted Drug EGFR RTK Inhibitors for NSCLC Product Specification


Section 4 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Region)
4.1 North America Country
4.1.1 United States Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.1.2 Canada Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.1.3 Mexico Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.2 South America Country
4.2.1 Brazil Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.2.2 Argentina Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.3 Asia Pacific
4.3.1 China Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.3.2 Japan Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.3.3 India Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.3.4 Korea Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.3.5 Southeast Asia Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.4 Europe Country
4.4.1 Germany Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.4.2 UK Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.4.3 France Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.4.4 Spain Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.4.5 Italy Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.5 Middle East and Africa
4.5.1 Africa Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.5.2 Middle East Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.6 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Region) Analysis 2016-2021
4.7 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Region) Analysis

Section 5 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (by Product Type)
5.1 Product Introduction by Type
5.1.1 Icotinib Product Introduction
5.1.2 Gefitinib Product Introduction
5.1.3 Erlotinib Product Introduction
5.1.4 Afatinib Product Introduction
5.1.5 Osimertinib Product Introduction
5.2 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume by Gefitinib016-2021
5.3 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size by Gefitinib016-2021
5.4 Different Targeted Drug EGFR RTK Inhibitors for NSCLC Product Type Price 2016-2021
5.5 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Type) Analysis

Section 6 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (by Application)
6.1 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume by Application 2016-2021
6.2 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size by Application 2016-2021
6.2 Targeted Drug EGFR RTK Inhibitors for NSCLC Price in Different Application Field 2016-2021
6.3 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Application) Analysis

Section 7 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (by Channel)
7.1 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Channel) Sales Volume and Share 2016-2021
7.2 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Channel) Analysis

Section 8 Targeted Drug EGFR RTK Inhibitors for NSCLC Market Forecast 2021-2026
8.1 Targeted Drug EGFR RTK Inhibitors for NSCLC Segmentation Market Forecast 2021-2026 (By Region)
8.2 Targeted Drug EGFR RTK Inhibitors for NSCLC Segmentation Market Forecast 2021-2026 (By Type)
8.3 Targeted Drug EGFR RTK Inhibitors for NSCLC Segmentation Market Forecast 2021-2026 (By Application)
8.4 Targeted Drug EGFR RTK Inhibitors for NSCLC Segmentation Market Forecast 2021-2026 (By Channel)
8.5 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Price Forecast

Section 9 Targeted Drug EGFR RTK Inhibitors for NSCLC Application and Client Analysis
9.1 Squamous Cell Carcinoma of NSCLC Customers
9.2 Adenocarcinoma of NSCLC Customers
9.3 Large Cell Carcinoma of NSCLC Customers

Section 10 Targeted Drug EGFR RTK Inhibitors for NSCLC Manufacturing Cost of Analysis
11.0 Raw Material Cost Analysis
11.0 Labor Cost Analysis
11.0 Cost Overview

Section 11 Conclusion

Section 12 Methodology and Data Source

Chart and Figure
Figure Targeted Drug EGFR RTK Inhibitors for NSCLC Product Picture
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size (with or without the impact of COVID-19)
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Growth Rate 2016-2021
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size (Million $) and Growth Rate 2016-2021
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Growth Rate 2021-2026
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size (Million $) and Growth Rate 2021-2026
Chart 2016-2021 Global Manufacturer Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units)
Chart 2016-2021 Global Manufacturer Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume Share
Chart 2016-2021 Global Manufacturer Targeted Drug EGFR RTK Inhibitors for NSCLC Business Revenue (Million USD)
Chart 2016-2021 Global Manufacturer Targeted Drug EGFR RTK Inhibitors for NSCLC Business Revenue Share
Chart Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Business Distribution
Chart Beta Pharma Interview Record (Partly)
Chart Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Business Profile
Table Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Product Specification
Chart AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Business Distribution
Chart AstraZeneca Interview Record (Partly)
Chart AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Business Overview
Table AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Product Specification


Chart United States Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart United States Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Canada Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Canada Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Mexico Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Mexico Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Brazil Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Brazil Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Argentina Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Argentina Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart China Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart China Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Japan Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Japan Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart India Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart India Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Korea Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Korea Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Southeast Asia Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Southeast Asia Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Germany Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Germany Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart UK Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart UK Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart France Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart France Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Spain Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Spain Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Italy Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Italy Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Africa Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Africa Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Middle East Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Middle East Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation Sales Volume (Units) by Region 2016-2021
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation Sales Volume (Units) Share by Region 2016-2021
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation Market size (Million $) by Region 2016-2021
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation Market size (Million $) Share by Region 2016-2021
Chart Icotinib Product Figure
Chart Icotinib Product Description
Chart Gefitinib Product Figure
Chart Gefitinib Product Description
Chart Erlotinib Product Figure
Chart Erlotinib Product Description
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) by Gefitinib016-2021
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) Share by Type
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size (Million $) by Gefitinib016-2021
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size (Million $) Share by Gefitinib016-2021
Chart Different Targeted Drug EGFR RTK Inhibitors for NSCLC Product Type Price ($/Unit) 2016-2021
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) by Application 2016-2021
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) Share by Application
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size (Million $) by Application 2016-2021
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size (Million $) Share by Application 2016-2021
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Price in Different Application Field 2016-2021
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Channel) Sales Volume (Units) 2016-2021
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Channel) Share 2016-2021
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Segmentation Market Sales Volume (Units) Forecast (by Region) 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Segmentation Market Sales Volume Forecast (By Region) Share 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Segmentation Market Size (Million USD) Forecast (By Region) 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Segmentation Market Size Forecast (By Region) Share 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Type) Volume (Units) 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Type) Volume (Units) Share 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Type) Market Size (Million $) 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Type) Market Size (Million $) 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Application) Market Size (Volume) 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Application) Market Size (Volume) Share 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Application) Market Size (Value) 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Application) Market Size (Value) Share 2021-2026
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Channel) Sales Volume (Units) 2021-2026
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Channel) Share 2021-2026
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Price Forecast 2021-2026
Chart Squamous Cell Carcinoma of NSCLC Customers
Chart Adenocarcinoma of NSCLC Customers
Chart Large Cell Carcinoma of NSCLC Customers


 

ページTOPに戻る


 

Summary

Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Status, Trends and COVID-19 Impact Report 2021
Single User License Report: 2350 USD
Corporate User License Report: 4700 USD
Section Price: As below

In the past few years, the Targeted Drug EGFR RTK Inhibitors for NSCLC market experienced a huge change under the influence of COVID-19, the global market size of Targeted Drug EGFR RTK Inhibitors for NSCLC reached (2021 Market size XXXX) million $ in 2021 from (2016 Market size XXXX) in 2016 with a CAGR of XXX from 2016-2021 is. As of now, the global COVID-19 Coronavirus Cases have exceeded 200 million, and the global epidemic has been basically under control, therefore, the World Bank has estimated the global economic growth in 2021 and 2022. The World Bank predicts that the global economic output is expected to expand 4 percent in 2021 while 3.8 percent in 2022. According to our research on Targeted Drug EGFR RTK Inhibitors for NSCLC market and global economic environment, we forecast that the global market size of Targeted Drug EGFR RTK Inhibitors for NSCLC will reach (2026 Market size XXXX) million $ in 2026 with a CAGR of % from 2021-2026.

Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to recover and partially adapted to pandemic restrictions. The research and development of vaccines has made breakthrough progress, and many governments have also issued various policies to stimulate economic recovery, particularly in the United States, is likely to provide a strong boost to economic activity but prospects for sustainable growth vary widely between countries and sectors. Although the global economy is recovering from the great depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged period. The pandemic has exacerbated the risks associated with the decade-long wave of global debt accumulation. It is also likely to steepen the long-expected slowdown in potential growth over the next decade.

The world has entered the COVID-19 epidemic recovery period. In this complex economic environment, we published the Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Status, Trends and COVID-19 Impact Report 2021, which provides a comprehensive analysis of the global Targeted Drug EGFR RTK Inhibitors for NSCLC market , This Report covers the manufacturer data, including: sales volume, price, revenue, gross margin, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows the regional development status, including market size, volume and value, as well as price data. Besides, the report also covers segment data, including: type wise, industry wise, channel wise etc. all the data period is from 2015-2021E, this report also provide forecast data from 2021-2026.

Section 1: 100 USD——Market Overview

Section (2 3): 1200 USD——Manufacturer Detail
Beta Pharma
AstraZeneca
Natco Pharma
Qilu Pharmaceutical
Genentech (Roche Group)
Mylan
Teva
OSI Pharmaceuticals
Glenmark Pharmaceuticals
Beacon Pharmaceuticals
Boehringer Ingelheim
Pfizer
ARIAD Pharmaceuticals (Takeda)
Genvio Pharma Limited
Drug International Limted
Everest Pharmaceuticals
Incepta Pharmaceuticals Limited
Cipla Pharma
Dr Reddy's Laboratories
Zydus Cadila
Hetero Drugs
Intas Pharmaceuticals
Alkem Laboratories
RPG Life Sciences
Fresenius Kabi India

Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)

Section (5 6 7): 700 USD——
Product Type Segmentation
Icotinib
Gefitinib
Erlotinib
Afatinib
Osimertinib

Application Segmentation
Squamous Cell Carcinoma of NSCLC
Adenocarcinoma of NSCLC
Large Cell Carcinoma of NSCLC

Channel (Direct Sales, Distribution Channel) Segmentation

Section 8: 500 USD——Market Forecast (2021-2026)

Section 9: 600 USD——Downstream Customers

Section 10: 200 USD——Raw Material and Manufacturing Cost

Section 11: 500 USD——Conclusion

Section 12: Research Method and Data Source



ページTOPに戻る


Table of Contents

Table of Contents
Section 1 Targeted Drug EGFR RTK Inhibitors for NSCLC Market Overview
1.1 Targeted Drug EGFR RTK Inhibitors for NSCLC Market Scope
1.2 COVID-19 Impact on Targeted Drug EGFR RTK Inhibitors for NSCLC Market
1.3 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Status and Forecast Overview
1.3.1 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Status 2016-2021
1.3.2 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Forecast 2021-2026

Section 2 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Manufacturer Share
2.1 Global Manufacturer Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume
2.2 Global Manufacturer Targeted Drug EGFR RTK Inhibitors for NSCLC Business Revenue

Section 3 Manufacturer Targeted Drug EGFR RTK Inhibitors for NSCLC Business Introduction
3.1 Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Business Introduction
3.1.1 Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume, Price, Revenue and Gross margin 2016-2021
3.1.2 Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Business Distribution by Region
3.1.3 Beta Pharma Interview Record
3.1.4 Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Business Profile
3.1.5 Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Product Specification

3.2 AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Business Introduction
3.2.1 AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume, Price, Revenue and Gross margin 2016-2021
3.2.2 AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Business Distribution by Region
3.2.3 Interview Record
3.2.4 AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Business Overview
3.2.5 AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Product Specification

3.3 Manufacturer three Targeted Drug EGFR RTK Inhibitors for NSCLC Business Introduction
3.3.1 Manufacturer three Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume, Price, Revenue and Gross margin 2016-2021
3.3.2 Manufacturer three Targeted Drug EGFR RTK Inhibitors for NSCLC Business Distribution by Region
3.3.3 Interview Record
3.3.4 Manufacturer three Targeted Drug EGFR RTK Inhibitors for NSCLC Business Overview
3.3.5 Manufacturer three Targeted Drug EGFR RTK Inhibitors for NSCLC Product Specification


Section 4 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Region)
4.1 North America Country
4.1.1 United States Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.1.2 Canada Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.1.3 Mexico Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.2 South America Country
4.2.1 Brazil Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.2.2 Argentina Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.3 Asia Pacific
4.3.1 China Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.3.2 Japan Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.3.3 India Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.3.4 Korea Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.3.5 Southeast Asia Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.4 Europe Country
4.4.1 Germany Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.4.2 UK Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.4.3 France Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.4.4 Spain Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.4.5 Italy Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.5 Middle East and Africa
4.5.1 Africa Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.5.2 Middle East Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size and Price Analysis 2016-2021
4.6 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Region) Analysis 2016-2021
4.7 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Region) Analysis

Section 5 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (by Product Type)
5.1 Product Introduction by Type
5.1.1 Icotinib Product Introduction
5.1.2 Gefitinib Product Introduction
5.1.3 Erlotinib Product Introduction
5.1.4 Afatinib Product Introduction
5.1.5 Osimertinib Product Introduction
5.2 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume by Gefitinib016-2021
5.3 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size by Gefitinib016-2021
5.4 Different Targeted Drug EGFR RTK Inhibitors for NSCLC Product Type Price 2016-2021
5.5 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Type) Analysis

Section 6 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (by Application)
6.1 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume by Application 2016-2021
6.2 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size by Application 2016-2021
6.2 Targeted Drug EGFR RTK Inhibitors for NSCLC Price in Different Application Field 2016-2021
6.3 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Application) Analysis

Section 7 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (by Channel)
7.1 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Channel) Sales Volume and Share 2016-2021
7.2 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Channel) Analysis

Section 8 Targeted Drug EGFR RTK Inhibitors for NSCLC Market Forecast 2021-2026
8.1 Targeted Drug EGFR RTK Inhibitors for NSCLC Segmentation Market Forecast 2021-2026 (By Region)
8.2 Targeted Drug EGFR RTK Inhibitors for NSCLC Segmentation Market Forecast 2021-2026 (By Type)
8.3 Targeted Drug EGFR RTK Inhibitors for NSCLC Segmentation Market Forecast 2021-2026 (By Application)
8.4 Targeted Drug EGFR RTK Inhibitors for NSCLC Segmentation Market Forecast 2021-2026 (By Channel)
8.5 Global Targeted Drug EGFR RTK Inhibitors for NSCLC Price Forecast

Section 9 Targeted Drug EGFR RTK Inhibitors for NSCLC Application and Client Analysis
9.1 Squamous Cell Carcinoma of NSCLC Customers
9.2 Adenocarcinoma of NSCLC Customers
9.3 Large Cell Carcinoma of NSCLC Customers

Section 10 Targeted Drug EGFR RTK Inhibitors for NSCLC Manufacturing Cost of Analysis
11.0 Raw Material Cost Analysis
11.0 Labor Cost Analysis
11.0 Cost Overview

Section 11 Conclusion

Section 12 Methodology and Data Source

Chart and Figure
Figure Targeted Drug EGFR RTK Inhibitors for NSCLC Product Picture
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size (with or without the impact of COVID-19)
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Growth Rate 2016-2021
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size (Million $) and Growth Rate 2016-2021
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Growth Rate 2021-2026
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size (Million $) and Growth Rate 2021-2026
Chart 2016-2021 Global Manufacturer Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units)
Chart 2016-2021 Global Manufacturer Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume Share
Chart 2016-2021 Global Manufacturer Targeted Drug EGFR RTK Inhibitors for NSCLC Business Revenue (Million USD)
Chart 2016-2021 Global Manufacturer Targeted Drug EGFR RTK Inhibitors for NSCLC Business Revenue Share
Chart Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Business Distribution
Chart Beta Pharma Interview Record (Partly)
Chart Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Business Profile
Table Beta Pharma Targeted Drug EGFR RTK Inhibitors for NSCLC Product Specification
Chart AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Business Distribution
Chart AstraZeneca Interview Record (Partly)
Chart AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Business Overview
Table AstraZeneca Targeted Drug EGFR RTK Inhibitors for NSCLC Product Specification


Chart United States Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart United States Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Canada Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Canada Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Mexico Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Mexico Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Brazil Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Brazil Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Argentina Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Argentina Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart China Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart China Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Japan Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Japan Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart India Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart India Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Korea Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Korea Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Southeast Asia Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Southeast Asia Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Germany Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Germany Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart UK Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart UK Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart France Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart France Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Spain Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Spain Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Italy Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Italy Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Africa Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Africa Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Middle East Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Middle East Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Price (USD/Unit) 2016-2021
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation Sales Volume (Units) by Region 2016-2021
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation Sales Volume (Units) Share by Region 2016-2021
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation Market size (Million $) by Region 2016-2021
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation Market size (Million $) Share by Region 2016-2021
Chart Icotinib Product Figure
Chart Icotinib Product Description
Chart Gefitinib Product Figure
Chart Gefitinib Product Description
Chart Erlotinib Product Figure
Chart Erlotinib Product Description
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) by Gefitinib016-2021
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) Share by Type
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size (Million $) by Gefitinib016-2021
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size (Million $) Share by Gefitinib016-2021
Chart Different Targeted Drug EGFR RTK Inhibitors for NSCLC Product Type Price ($/Unit) 2016-2021
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) by Application 2016-2021
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Sales Volume (Units) Share by Application
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size (Million $) by Application 2016-2021
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size (Million $) Share by Application 2016-2021
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Price in Different Application Field 2016-2021
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Channel) Sales Volume (Units) 2016-2021
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Channel) Share 2016-2021
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Segmentation Market Sales Volume (Units) Forecast (by Region) 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Segmentation Market Sales Volume Forecast (By Region) Share 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Segmentation Market Size (Million USD) Forecast (By Region) 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Segmentation Market Size Forecast (By Region) Share 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Type) Volume (Units) 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Type) Volume (Units) Share 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Type) Market Size (Million $) 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Type) Market Size (Million $) 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Application) Market Size (Volume) 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Application) Market Size (Volume) Share 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Application) Market Size (Value) 2021-2026
Chart Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Application) Market Size (Value) Share 2021-2026
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Channel) Sales Volume (Units) 2021-2026
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Segmentation (By Channel) Share 2021-2026
Chart Global Targeted Drug EGFR RTK Inhibitors for NSCLC Price Forecast 2021-2026
Chart Squamous Cell Carcinoma of NSCLC Customers
Chart Adenocarcinoma of NSCLC Customers
Chart Large Cell Carcinoma of NSCLC Customers


 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

本レポートと同じKEY WORD(drug)の最新刊レポート


よくあるご質問


BisReport Consulting Co., Ltd.社はどのような調査会社ですか?


BisReport Consultingは北米、欧州、中国、日本、インド、韓国、東南アジアなどの世界主要国/地域の企業に化学品、材料、自動車、機械、医薬品、医療機器などの市場情報を提供しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20 10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る